Foscarnet-induced electrolyte abnormalities in a bone marrow transplant patient receiving parenteral nutrition.

Matarese LE, Speerhas R, Seidner DL, Steiger E
JPEN J Parenter Enteral Nutr. 2000 24 (3): 170-3

PMID: 10850943 · DOI:10.1177/0148607100024003170

Cytomegalovirus (CMV) is a serious complication of immunosuppressed patients receiving bone marrow transplantation. Foscarnet, a pyrophosphate analog, has been used in the treatment of CMV infections. Renal impairment and electrolyte abnormalities are potential adverse reactions associated with the use of foscarnet. We report a case of significant electrolyte changes after initiation of foscarnet in a bone marrow transplant patient receiving parenteral nutrition.

MeSH Terms (10)

Adult Antiviral Agents Bone Marrow Transplantation Cytomegalovirus Cytomegalovirus Infections Electrolytes Foscarnet Humans Male Parenteral Nutrition, Total

Connections (1)

This publication is referenced by other Labnodes entities:

Links